Nature Medicine, Published online: 19 February 2026; doi:10.1038/s41591-026-04206-y
Plasma p-tau217 tests used to develop clocks that predict when cognitively unimpaired individuals would develop symptoms of Alzheimerʼs disease.- February 19, 2026
- 0 Comment
- February 18, 2026
- 0 Comment
Nature Medicine, Published online: 18 February 2026; doi:10.1038/s41591-026-04235-7
This multidisciplinary response to investigate the large outbreak of unknown febrile illness in the Panzi Health Zone in the Democratic Republic of the Congo in late 2024 suggests that the outbreak was largely associated with malarial cases and concurrent viral respiratory infections.- February 18, 2026
- 0 Comment
Nature Medicine, Published online: 18 February 2026; doi:10.1038/s41591-026-04201-3
Stem-cell-derived islet cells could transform type 1 diabetes by removing the need for injected or infused insulin and improving quality of life. But evaluation of these therapies must center on the voices of people living with type 1 diabetes and examine meaningful outcomes.- February 18, 2026
- 0 Comment
- February 17, 2026
- 0 Comment
Nature Medicine, Published online: 17 February 2026; doi:10.1038/s41591-026-04226-8
Designing interventions that fit seamlessly into real-world care settings is crucial to curtailing rising antimicrobial resistance in resource-limited settings; a large, pragmatic trial in China shows that this is feasible.- February 17, 2026
- 0 Comment
Nature Medicine, Published online: 17 February 2026; doi:10.1038/s41591-026-04222-y
A pragmatic, cluster randomized trial in rural Guangdong, China, showed that 12-month implementation of a comprehensive antibiotic stewardship program involving physician training, point-of-care prompts, monthly peer review feedback and smartphone-based patient education substantially reduced antibiotic prescriptions for acute respiratory infections compared to control consultations.- February 17, 2026
- 0 Comment
Nature Medicine, Published online: 16 February 2026; doi:10.1038/s41591-026-04212-0
Using two newly developed immunoassays tested in three clinical cohorts, this study highlights CSF DOPA decarboxylase as a promising biomarker for differentiating dementia with Lewy bodies and Parkinson’s disease from Alzheimer’s disease and controls.- February 16, 2026
- 0 Comment
Nature Medicine, Published online: 16 February 2026; doi:10.1038/s41591-026-04258-0
Recent failures in high-profile clinical trials of neurodegenerative diseases highlight the need to rebalance clinical ambition and biological understanding.- February 16, 2026
- 0 Comment
Nature Medicine, Published online: 16 February 2026; doi:10.1038/s41591-026-04231-x
Precision nutrition must consider cost-effectiveness to deliver benefits to patients- February 16, 2026
- 0 Comment



